Baseline neutrophil-to-lymphocyte ratio (NLR) is associated with clinical outcome in recurrent or metastatic head and neck cancer patients treated with nivolumab

T Ueda, N Chikuie, M Takumida, H Furuie… - Acta Oto …, 2020 - Taylor & Francis
… with clinical benefit from nivolumab in patients with R/M HNC. We propose that baseline
NLR be used as a predictive or prognostic marker for nivolumab efficacy in these patients. …

Prognostic significance of baseline neutrophil count and lactate dehydrogenase level in patients with esophageal squamous cell cancer treated with radiotherapy

HS Luo, HY Xu, ZS Du, XY Li, SX Wu, HC Huang… - Frontiers in …, 2020 - frontiersin.org
… The neutrophil count divided by the lymphocyte count was defined as the … about the
prognostic significance of the LDH level and neutrophil count in ESCC patients treated with …

[HTML][HTML] The prognostic value of neutrophil-to-lymphocyte ratio and monocyte-to-lymphocyte ratio in metastatic gastric cancer treated with systemic chemotherapy

D Zhou, Y Wu, Y Zhu, Z Lin, D Yu, T Zhang - Journal of cancer, 2020 - ncbi.nlm.nih.gov
… Based on this background, the aim of this study was to investigate the prognostic role of
the NLR and MLR for survival in mGC patients with first- and second-line strategy. …

… prognostic and predictive role of the neutrophil-to-lymphocyte ratio (NLR), platelet-to-lymphocyte ratio (PLR), and lymphocyte-to-monocyte ratio (LMR) as biomarkers …

S Maloney, N Pavlakis, M Itchins, J Arena… - Journal of Clinical …, 2023 - mdpi.com
… and as a prognostic marker in all patients that … patients with a higher neutrophil-to-lymphocyte
ratio (>5) at the time of diagnosis had worse median overall survival than those with ratios

Decrease in neutrophil-to-lymphocyte ratio during neoadjuvant chemotherapy as a predictive and prognostic marker in advanced ovarian cancer

E Sanna, L Tanca, C Cherchi, G Gramignano, S Oppi… - Diagnostics, 2021 - mdpi.com
… In the present study, 161 patients with advanced ovarian, fallopian tube, or primary
peritoneal HGSC were prospectively enrolled, and the prognostic significance of the NLR was …

The neutrophil-to-lymphocyte ratio is a prognostic biomarker in an ethnically diverse patient population with advanced pancreatic cancer

M Shusterman, E Jou, A Kaubisch, JW Chuy… - Journal of …, 2020 - Springer
… The NLR was calculated using the baseline neutrophil and lymphocyte count obtained on
the day of or within 48 h preceding chemotherapy administration. A NLR cutoff of ≤ 5 or > 5 …

Significance of neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio, lymphocyte-to-monocyte ratio and prognostic nutritional index for predicting clinical …

L Xia, W Li, J Zhai, C Yan, J Chen, H Yang - BMC cancer, 2020 - Springer
advanced RCs [8, 14, 17, 18]. To the best of our knowledge, the prognostic significance of
… Our study aimed to detect the role of NLR, PLR, LMR, and PNI in predicting the prognosis of …

[HTML][HTML] Predictability of early changes in derived neutrophil-to-lymphocyte ratio and neutrophil-to-lymphocyte ratio in patients with advanced non-small cell lung …

JU Lim, HS Kang, CD Yeo, JS Kim… - Journal of Thoracic …, 2021 - ncbi.nlm.nih.gov
… was shown to predict poor prognosis in both hematologic and … prognostic value in patients
with advanced NSCLC who were receiving ICI (22,23), the biomarkers measured at baseline

Prognostic value of platelet-to-lymphocyte ratio, neutrophil-to-lymphocyte ratio, and lymphocyte-to-white blood cell ratio in colorectal cancer patients who received …

W Jia, L Yuan, H Ni, B Xu… - Technology in Cancer …, 2021 - journals.sagepub.com
… study was to assess the prognostic value of pretreatment platelet-to-lymphocyte ratio (PLR), …
the significance of PLR, NLR, and LWR as prognostic predictors for survival of CRC patients

Prognostic value of the early change in neutrophil-to-lymphocyte ratio in metastatic pancreatic adenocarcinoma

P McLellan, J Henriques, F Ksontini, S Doat… - Clinics and research in …, 2021 - Elsevier
… In metastatic pancreatic adenocarcinoma, a high neutrophil-to-lymphocyte ratio (NLR) at
diagnosis is a marker of poor prognosis. The prognostic role of baseline NLR and NLR change …